« The DRAM, Vol. 6(3) – Pass or fail? College students, binge drinking and academic performance. | Main | Addiction & the Humanities, Vol. 6(4) - A diary of morphine-addiction »

Wednesday, April 21, 2010

Comments

The largest trial of electronic cigarettes so far, of 40 participants and conducted in New Zealand in 2009, shows that the nicotine e-cigarette significantly reduces cravings.
Bullen et al, Tobacco Control journal, published 9 April 2010. Full text at www.healthnz.co.nz/News2010.htm

As in the Eissenberg trial above, we reported low nicotine delivery in comparison with own brand cigarettes on a puff by puff basis. However, no-one has so far formally characterised how committed vapers use e-cigarettes. Many appear to puff very frequently, (feasible, as no lighting up involved). Two puffs every 5 minutes equals 24 puffs per hour, as against 7-20 puffs for a tobacco cigarette.

Also both trials refer to first generation e-cigarettes. In the last year vapers have been busy modifying these cigarettes (www.vapersclub.com) to deliver a noticeable nicotine kick, and factories in China can rapidly manufacture to new designs. Further research is needed to keep up with developments.

The e-cigarette with its visible “smoke” may raise smokers’ expectations – a partial placebo effect. The New Zealand study (blinded for strength) found a strong placebo effect in the first 15 minutes, before this was overtaken by the full strength e-cigarette effect. The full strength e-cigarettes was preferred to the medicinal nicotine inhaler, as more pleasant to use, the vapor being less harsh.

I welcome contacts from others interested in researching e-cigarettes further.

Murray Laugesen e-cigarette researcher www.healthnz.co.nz
(no financial interest in nicotine or tobacco companies).

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name and email address are required. Email address will not be displayed with the comment.)

The BASIS is a product of the Division on Addiction, Cambridge Health Alliance, a Harvard Medical School teaching hospital. The Division is an entirely self-funded academic organization that relies on grants, contracts, and gifts in order to produce The BASIS and our other high-quality work.
Donate5
Subscribe9